These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advances in the treatment of renal disease. Robson JS Practitioner; 1969 Oct; 203(216):483-93. PubMed ID: 4902939 [No Abstract] [Full Text] [Related]
3. Diagnosis, management, and prevention of renal disease in children. Barakat AY Compr Ther; 1989 Oct; 15(10):60-8. PubMed ID: 2680245 [No Abstract] [Full Text] [Related]
4. Recovery from rapidly progressive glomerulonephritis. Improvement after plasmapheresis and immunosuppression. Warren SE; Mitas JA; Golbus SM; Swerdlin AR; Cohen IM; Cronin RE Arch Intern Med; 1981 Feb; 141(2):175-80. PubMed ID: 7006545 [TBL] [Abstract][Full Text] [Related]
5. [Our experience with immunosuppressive therapy of kidney diseases in childhood]. Principi N; Gaboardi F; Chiccoli C Minerva Pediatr; 1969 Nov; 21(45):2117-24. PubMed ID: 5405687 [No Abstract] [Full Text] [Related]
6. [Clinical and basic studies on immunosuppressive agents in renal disease]. Nihon Jinzo Gakkai Shi; 1993 May; 35(5):438-45. PubMed ID: 8361092 [No Abstract] [Full Text] [Related]
7. Mortality in pediatric renal transplantation: a study of the French pediatric kidney database. Allain-Launay E; Roussey-Kesler G; Ranchin B; Guest G; Maisin A; Novo R; André JL; Cloarec S; Guyot C Pediatr Transplant; 2009 Sep; 13(6):725-30. PubMed ID: 19691564 [TBL] [Abstract][Full Text] [Related]
8. Progressive renal disease despite immunosuppressive therapy in a patient with Wegener s granulomatosis. Klein I; Vervoort G; Steenbergen E; Wetzels J Neth J Med; 2008 Mar; 66(3):125-7. PubMed ID: 18349469 [TBL] [Abstract][Full Text] [Related]
9. An inventory of our therapeutic possessions. Coe FL Med Clin North Am; 1978 Nov; 62(6):1147-56. PubMed ID: 84097 [No Abstract] [Full Text] [Related]
11. [Immunosuppression in renal diseases]. Brodwall EK Tidsskr Nor Laegeforen; 1969 Nov; 89(21):1650-2. PubMed ID: 5398052 [No Abstract] [Full Text] [Related]
12. [Physiopathologic and therapeutic differences between primary and secondary kidney diseases]. Nagasawa T Nihon Naika Gakkai Zasshi; 1992 Jan; 81(1):3-6. PubMed ID: 1556459 [No Abstract] [Full Text] [Related]
13. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression. Isbister JP; Ralston M; Hayes JM; Wright R Arch Intern Med; 1981 Jul; 141(8):1081-3. PubMed ID: 7247596 [TBL] [Abstract][Full Text] [Related]
14. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis. Oliveira L; Wang D; McCormick BB Ther Apher Dial; 2007 Jun; 11(3):227-31. PubMed ID: 17498006 [TBL] [Abstract][Full Text] [Related]
15. [The use of immunosuppressive agents for children]. Lévêque B; Donea M Ann Pediatr (Paris); 1967 Mar; 14(3):248-57. PubMed ID: 5614549 [No Abstract] [Full Text] [Related]
16. [Therapeutic use of plasmapheresis in internal and skin diseases]. Nenov D; Nenov K; Penev Z; Chankova P Vutr Boles; 1989; 28(4):129-31. PubMed ID: 2596085 [No Abstract] [Full Text] [Related]